MojiaBio

What MojiaBio does

MojiaBio (摩珈生物), founded in 2018 and headquartered operationally in Singapore with primary R&D in Shanghai Zhangjiang and a manufacturing site in Sichuan Guang'an, is a synthetic biology company that develops and commercializes bio-based polymers and feed additives produced via fermentation and biocatalysis. Its commercial portfolio centers on two product brands: Aliphane®, a series of bio-based polyurethane and polyurea systems with greater than 70% bio-content used in coatings, adhesives, sealants, and elastomers for automotive, marine, construction, and industrial applications; and Viridimin®, including a Vitamin B5 (calcium pantothenate) product manufactured via a patented ambient-condition bio-process and sold to animal nutrition and food fortification customers. The company also produces bio-based aroma chemicals and is developing C1-based routes to molecules such as 1,3-propanediol (PDO).

The technical backbone comprises two proprietary platforms. OrthBio® decouples biomass conversion from target product synthesis, enabling parallel product development and reducing capital intensity, energy use, and development cycles relative to traditional fermentation. C1+Bio™ (also referenced as Cn+Bio™) is a new-to-nature metabolic pathway that converts non-food C1 feedstocks—methanol, formic acid, and CO2—into high-value chemicals, providing feedstock optionality and a claimed greater than 60% carbon footprint reduction versus petrochemical incumbents. The FORCE (Formyl-CoA FORance Extension) reaction underpins this chemistry. Operations are supported by an in-house manufacturing facility in Guang'an (using AIoT smart energy management), a near-100-person joint research team at the Xianghu Laboratory in Hangzhou, and an R&D presence in Singapore (including the SGD 44.8M SBTP platform with A*STAR and NUS) and Florida, USA.

MojiaBio sells directly to enterprise customers in target verticals through a B2B field-sales motion focused on co-development with "leading global brands." Revenue is generated through product sales rather than licensing or royalties, with pricing not publicly disclosed. The company has raised approximately $80M in a June 2022 Series B led by Temasek, with prior backing from Asia Green Fund, Bits x Bites, LYZZ Capital, Sento Investment, and Green Capital. No disclosed revenue, ARR, or GMV figures are available in the source material.

Name

MojiaBio

Legal name

MOJIABIO

Website

https://mojiabio.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

MojiaBio is a synthetic biology company that produces bio-based polymers (Aliphane®) and Vitamin B5 feed additives (Viridimin®) using its OrthBio® and C1+Bio™ platforms, selling to enterprise customers in coatings, adhesives, automotive, personal care, and animal nutrition.

Ownership category

akta.pro rank

Product category

Bio-based Specialty Chemicals

NAICS

Resin and Synthetic Rubber Manufacturing (32521), Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing (325194), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Industrial Organic Chemicals (2860), Adhesives & Sealants (2891), Food And Kindred Products (2000)

akta.pro primary industry

Bio-based Resins, Adhesives, Coatings & Sealants (EUAAAIAG)

akta.pro secondary industries

Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB), Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents) (EUAAAIAB)

Keywords

• Synthetic biology manufacturing
• Bio-based polymer materials
• Animal feed additives
• Green chemistry production
• Carbon neutral chemicals

Headquarters

HQ city

Guangan

HQ country

China

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D

Revenue model

1. Bio-based Materials Sales: Sale of Aliphane® series bio-based polymer products (polyurethane/polyurea systems) for coatings, adhesives, sealants, elastomers. Sold directly to manufacturers in automotive, industrial, marine, construction, and other sectors.
2. Feed Additives Sales: Sale of Viridimin® B5 (Vitamin B5) as animal feed additive and food fortification ingredient. Distributed to animal nutrition and food processing companies.
3. Aroma & Care Products: Sale of bio-based aroma chemicals produced through synthetic biology and green chemistry conversion of biomass (glucose, glycerol, dipentene) into high-value, low-carbon fragrance and flavor products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

MojiaBio manufactures and sells bio-based chemical products produced through synthetic biology and proprietary biomanufacturing platforms. Its commercial offerings include the Aliphane® series of bio-based polyurethane and polyurea polymers for use in coatings, adhesives, sealants, and elastomers, and Viridimin® (including Vitamin B5) feed and food fortification additives. These products are enabled by two proprietary technology platforms — OrthBio® for decoupling biomass conversion from product synthesis, and C1+Bio™ for converting non-food C1 feedstocks such as methanol and CO2 into target chemicals.

Product overview

MojiaBio is a biomanufacturing company offering a portfolio of products centered on two main brands: Aliphane® (bio-based polymer materials for coatings, adhesives, sealants, and elastomers) and Viridimin® (feed additives including Vitamin B5). These products are enabled by two proprietary technology platforms: OrthBio® (a parallel architecture that decouples biomass conversion from product synthesis for faster development cycles) and C1+Bio™ (a new-to-nature metabolic pathway utilizing C1 carbon sources like methanol for cost-efficient production). The company also operates a Sustainable Biomanufacturing Technology Platform (SBTP) developed with A*STAR for producing bio-based molecules including 1,3-propanediol (PDO).

Differentiator

Problem solved

Functional benefit

Brands

• Viridimin®: Brand of animal feed additives including Vitamin B5, produced using a gentle biological method that eliminates high-temperature and high-pressure processes.
• Aliphane®
• OrthBio®
• Cn+Bio™

Products and services

• Aliphane® Bio-based Polymer Products Series of bio-based polyurethane/polyurea systems offering high bio-content (>70%) with excellent UV and chemical resistance and a wide processing window. Sold to manufacturers of coatings, adhesives, sealants, and elastomers serving automotive, industrial, marine, construction, renewable energy, footwear, 3D printing, and textile applications as a sustainable alternative to petroleum-based polyurethanes.
• Viridimin® B5 (Vitamin B5) Vitamin B5 (D-pantothenic acid) produced via a patented biological process that operates under ambient conditions, eliminating the high-temperature, high-pressure steps used in traditional chemical production. Sold as an essential nutrient additive for animal feed premixes and as a food fortification ingredient for cereals, bread, and dairy products.
• Sustainable Biomanufacturing Technology Platform (SBTP) Sustainable biomanufacturing technology platform developed with A*STAR and partners (NUS, A*STAR ISCE2/SIFBI) that integrates synthetic biology, enzyme engineering, computational modeling, and bioprocessing to produce bio-based molecules such as 1,3-propanediol (PDO) for use in textiles, automotive, personal care, coatings, and biodegradable plastics.

Quantifiable outcome

• Over 7 million barrels of oil reduction per year from 400 KT Aliphane® production
• +6 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core, supporting and major.

• Xianghu Laboratory (湘湖实验室)coreStrategic or Co-development Partner · 7 March 2025Joint Synthetic Biology Innovation Center established in Hangzhou with thousands of square meters of laboratory space. Nearly 100-person research team led by Dr. Ramon Gonzalez focusing on amino acid green manufacturing, plant functional ingredients, chassis cell technology upgrades, new bio-based materials development, food security solutions, and collaborative areas.
• A*STAR (Agency for Science, Technology and Research)coreStrategic or Co-development Partner · 28 February 2025SGD 44.8 million collaboration to develop Sustainable Biomanufacturing Technology Platform (SBTP) integrating advanced synthetic biology and bioprocessing innovations. A*STAR SIFBI provides enzyme engineering expertise for faster, more reliable, higher-yield conversion. Platform aims to produce bio-based molecules like 1,3-propanediol (PDO) cost-competitive with conventional processes using methanol and ethylene glycol.
• A*STAR Institute of Sustainability for Chemicals, Energy and Environment (ISCE2)coreTechnology or Integration · 28 February 2025Provides synthetic biology and enzyme engineering capabilities for the SBTP collaboration
• National University of Singapore (NUS)supportingTechnology or Integration · 28 February 2025Provides computational modeling expertise to engineer enzymes and microbial strains for the SBTP platform
• Hunan Haili (湖南海利)majorStrategic or Co-development Partner · 20 June 2024Strategic cooperation agreement for R&D and industrialization collaboration to jointly promote the prosperity and development of the biomanufacturing industry.
• Dongfang Low Carbon (东方低碳)supportingStrategic or Co-development Partner · 1 January 2024Connected through shareholder Asia Green Fund. Provides energy-saving and emission-reduction service solutions for company's Guang'an factory, implementing AIoT smart energy management platform and waste heat recovery projects.

Scale indicators10 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Genomatica: Genomatica develops bio-based process technologies for widely-used chemicals (e.g., bio-BDO, bio-butylene glycol) via engineered microbes. Direct peer on bio-based platform chemicals targeting industrial-scale substitution of petrochemical inputs.
• Carbios: Carbios develops enzymatic recycling and bio-based monomer technologies (e.g., bio-PEF, bio-MBH) for plastics and polymers. Comparable technology approach (biocatalysis for polymer feedstocks) and end-markets (coatings, packaging polymers).
• Amyris: Amyris pioneered synthetic biology for specialty ingredients (squalane, fragrances, sweeteners) using engineered yeast. Comparable technology and product focus on bio-based aroma/specialty chemicals, though illustrates execution and capital risks in the category.
• Conagen: Conagen is a US-based synthetic biology firm producing high-value ingredients (vitamins, flavors, amino acids) via fermentation. Closely comparable to MojiaBio on technology (precision fermentation) and end-markets (Vitamin B5, aroma chemicals); Dr. Gonzalez also serves on its advisory board.
• Cathay Biotech: Cathay Biotech is a leading Chinese bio-manufacturer of long-chain bio-based polyamides (e.g., bio-pentanediamine) used in coatings, adhesives, and engineering plastics. Directly comparable to MojiaBio on bio-based polymer platform targeting same downstream coatings and automotive customers in China.
• LanzaTech: LanzaTech is a synthetic biology company that gasifies waste gases (CO, CO2) into fuels and chemicals using proprietary carbon-fixing microbes. Direct overlap with MojiaBio's C1+Bio™ non-food feedstock thesis and Dr. Gonzalez serves on its advisory board, signaling comparable technology positioning.

Broad incumbents

• Ginkgo Bioworks: Ginkgo Bioworks operates a large-scale synthetic biology platform serving multiple end-markets including specialty chemicals, flavors, and industrial enzymes. Broader and more diversified than MojiaBio but competes for similar industrial bio-manufacturing customers and talent.
• CJ CheilJedang / CJ BIO: CJ CheilJedang is a large Korean fermentation producer of amino acids, nucleotides, and bio-based specialty ingredients including Vitamin B5. Comparable to MojiaBio on bio-based feed additives and platform fermentation technology at industrial scale.
• DuPont Tate & Lyle Bio Products: Joint venture producing bio-based 1,3-propanediol (Bio-PDO™) from corn sugar for cosmetics, personal care, and polymers. Incumbent in the bio-PDO category that MojiaBio's SBTP platform is targeting as a new entrant.

Emerging players

• Bloom Biorenewables: Bloom Biorenewables develops bio-based alternatives to fossil-derived polymers (e.g., furan-based resins) for coatings, adhesives, and composites. Emerging peer with direct overlap on bio-based polymer platform targeting the same coatings/adhesives end-markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mojia-biotech

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MojiaBio